This may relate to reduced caloric intake, metabolic adaptation, or the general adjustment period
What should actually drive the choice between a single and a dual agonist
Steen, D
With proper monitoring and personalized dosing, GLP-1 therapy can be effective across all CKD stages, including for patients on dialysis or post-transplant
In animal studies, it suppresses appetite and reduces body weight with effect sizes that are, in early reads, comparable to the GLP-1 class
Results and discussion Method optimization and development HPTLC method Experiments employing various solvent systems, such as ethyl acetate + cloroform (4:4, 8:2, 9:1, 2:8, and 9.5:0.5, v/v), revealed inadequate separation of the compounds under investigation and the appearance of tailed peaks